- Home
- MAIA
as 06-03-2025 4:00pm EST
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 46.7M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 209.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.40 - $5.99 | Next Earning Date: | 05-09-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of MAIA Biotechnology Inc. (MAIA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Smith Stan | MAIA | Director | May 8 '25 | Buy | $1.50 | 66,666 | $99,999.00 | 1,271,726 | |
| Guerrero Ramiro | MAIA | Director | May 8 '25 | Buy | $1.50 | 20,000 | $30,000.00 | 588,218 |
Latest MAIA Biotechnology Inc. News
MAIA Breaking Stock News: Dive into MAIA Ticker-Specific Updates for Smart Investing
Insider Monkey
7 days ago
MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
Business Wire
7 days ago
CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000
Business Wire
20 days ago
MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
Business Wire
21 days ago
MAIA Biotechnology Announces Director Participation in Recent Private Placement
Zacks
a month ago
Best Momentum Stocks to Buy for May 6th
Zacks
a month ago
New Strong Buy Stocks for May 6th
Business Wire
a month ago
CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement
Business Wire
a month ago
MAIA Biotechnology Announces $1.08 Million Private Placement
Compare MAIA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MAIA MAIA Biotechnology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.